{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:05:40Z","timestamp":1787861140181,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["212252\/Z\/18\/Z"],"award-info":[{"award-number":["212252\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.kint.2020.09.028","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T03:33:32Z","timestamp":1603856012000},"page":"396-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Complement activity is regulated in C3 glomerulopathy by IgG\u2013factor H fusion proteins with and without properdin targeting domains"],"prefix":"10.1016","volume":"99","author":[{"given":"Alyssa C.","family":"Gilmore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Terence","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah P.","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Katti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista K.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SungKwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1153-0192","authenticated-orcid":false,"given":"Matthew C.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2020.09.028_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrneph.2010.85","article-title":"C3 glomerulopathy: a new classification","volume":"6","author":"Fakhouri","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2020.09.028_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy\u2014understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2020.09.028_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","article-title":"Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals","volume":"151","author":"Pickering","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.116.1.1","article-title":"C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase","volume":"116","author":"Daha","year":"1976","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib5","first-page":"73","article-title":"Effect of nephritic factor on C3 and on the terminal pathway of complement in\u00a0vivo and in\u00a0vitro","volume":"65","author":"Mollnes","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib6","first-page":"450","article-title":"C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase","volume":"65","author":"Ng","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2020.09.028_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1681\/ASN.2012060570","article-title":"Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis","volume":"24","author":"Lesher","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.09.028_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1681\/ASN.2012060571","article-title":"Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency","volume":"24","author":"Ruseva","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.09.028_bib10","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.molimm.2009.03.030","article-title":"Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase","volume":"46","author":"Paixao-Cavalcante","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ki.2010.132","article-title":"Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice","volume":"78","author":"Fakhouri","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.09.028_bib12","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.2015070745","article-title":"Moss-produced, glycosylation-optimized human factor H for therapeutic application in complement disorders","volume":"28","author":"Michelfelder","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.09.028_bib13","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/ki.2015.233","article-title":"An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy","volume":"88","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.09.028_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2014121195","article-title":"Efficacy of targeted complement inhibition in experimental C3 glomerulopathy","volume":"27","author":"Ruseva","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.09.028_bib15","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1681\/ASN.2017091006","article-title":"An engineered complement factor H construct for treatment of C3 glomerulopathy","volume":"29","author":"Yang","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.09.028_bib16","first-page":"179","article-title":"Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis","volume":"142","author":"Schulze","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2020.09.028_bib17","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2215\/CJN.09541010","article-title":"Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees","volume":"6","author":"Athanasiou","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.09.028_bib18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20051900","article-title":"Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors","volume":"203","author":"Kaneko","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2020.09.028_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2249.1997.4261438.x","article-title":"Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice","volume":"110","author":"Sheerin","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib20","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.molimm.2005.05.011","article-title":"Comparison of surface recognition and C3b binding properties of mouse and human complement factor H","volume":"43","author":"Cheng","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2010050451","article-title":"The development of atypical hemolytic uremic syndrome depends on complement C5","volume":"22","author":"de Jorge","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.09.028_bib22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2020.09.028_bib23","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.4049\/jimmunol.1501388","article-title":"Complement evasion mediated by enhancement of captured factor H: implications for protection of self-surfaces from complement","volume":"195","author":"Herbert","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib24","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1073\/pnas.1219260110","article-title":"Dimerization of complement factor H-related proteins modulates complement activation in\u00a0vivo","volume":"110","author":"Goicoechea de Jorge","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2020.09.028_bib25","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.4049\/jimmunol.1203548","article-title":"Rational engineering of a minimized immune inhibitor with unique triple-targeting properties","volume":"190","author":"Schmidt","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.kint.2018.09.027","article-title":"Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis","volume":"95","author":"Wilson","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.09.028_bib27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4049\/jimmunol.1602017","article-title":"Modulation of the alternative pathway of complement by murine factor H-related proteins","volume":"200","author":"Antonioli","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3389\/fimmu.2017.01145","article-title":"The murine factor H-related rrotein FHR-B promotes complement activation","volume":"8","author":"Cserhalmi","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ekir.2019.06.008","article-title":"Glomerular complement factor H-related protein 5 (FHR5) is highly prevalent in C3 glomerulopathy and associated with renal impairment","volume":"4","author":"Medjeral-Thomas","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2020.09.028_bib30","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.4049\/jimmunol.1202275","article-title":"Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice","volume":"190","author":"Miwa","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/cei.12754","article-title":"Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy","volume":"184","author":"Corvillo","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2020.09.028_bib32","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2215\/CJN.01820214","article-title":"Defining the complement biomarker profile of C3 glomerulopathy","volume":"9","author":"Zhang","year":"2014","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820312370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820312370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:54:38Z","timestamp":1777474478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253820312370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0085253820312370"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2020.09.028","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement activity is regulated in C3 glomerulopathy by IgG\u2013factor H fusion proteins with and without properdin targeting domains","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2020.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}